|Articles|October 6, 2015

SERUM HER2: An under-utilized useful biomarker (sponsored)

Expand the practical, clinical use of effective monitoring of tumor biomarkers to improve care of women with breast cancer. Learn more by downloading and reading this supplement.

Published as a promotional supplement to Contemporary OB/GYN

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe

Related Content

Mark Simon, MD, MMM, on the hospitalist care model

Mark Simon, MD, MMM, on the OB hospitalist care model

ByMark Simon, MD, MMM

June 10th 2026

Bowel-prompted delivery in gastroschisis not associated with improved neonatal outcomes, 20-year study finds

ByContemporary OB/GYN Staff

June 9th 2026

Weekly review: Individualized TRT, acetaminophen safety reaffirmed, and more

ByJoshua Fitch, Senior Editor

June 6th 2026

Justin Drake, PhD, explains the Certitude Breast blood test for early breast cancer detection

ByJustin Drake, PhD

June 4th 2026

Clinical pearls into new postmenopausal guidelines from ACOG, with Susan Loeb-Zeitlin, MD, FACOG

Clinical pearls into ACOG's postmenopausal bleeding guidelines with Susan Loeb-Zeitlin, MD, FACOG

BySusan E. Loeb-Zeitlin, MD, FACOG

June 4th 2026

Latest CME

Video

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

SERUM HER2: An under-utilized useful biomarker (sponsored)

Related Content

Mark Simon, MD, MMM, on the OB hospitalist care model

Bowel-prompted delivery in gastroschisis not associated with improved neonatal outcomes, 20-year study finds

Weekly review: Individualized TRT, acetaminophen safety reaffirmed, and more

Justin Drake, PhD, explains the Certitude Breast blood test for early breast cancer detection

Clinical pearls into ACOG's postmenopausal bleeding guidelines with Susan Loeb-Zeitlin, MD, FACOG

Latest CME

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Trending on Contemporary OB/GYN

Addressing Cognitive Symptoms and Transitioning from MHT to Non-Hormonal Therapy for VMS

Evaluating Newer Non-Hormonal Therapies for VMS

Contraception counseling is essential at GLP-1 RA initiation in reproductive-age patients

Neurokinin Pathways and the Rationale for NK Receptor Antagonism in Treating VMS

Mark Simon, MD, MMM, on the OB hospitalist care model